BiotechTube
Home/Arthrosi Therapeutics/Robert Keenan, MD
RK

Robert Keenan, MD

Chief Medical Officer

Arthrosi Therapeutics

Therapeutic Areas

GoutInflammatory Diseases

Arthrosi Therapeutics Pipeline

DrugIndicationPhase
AR882 (Pozdeutinurad)Gout and Tophaceous GoutPhase 3

Leadership Team at Arthrosi Therapeutics

LY
Litain Yeh, PhD
Co-Founder & Chief Executive Officer
View full Arthrosi Therapeutics profile